Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Three Brothers Trading, LLC v. Generex Biotechnology Corp.
Case Number:
1:18-cv-11585
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 29, 2022
Biotech Co.'s Creditor Wants In On $3.8M Award Dispute
A New York City investment firm asked a federal judge to let it intervene in a dispute over a $3.8 million international arbitration award against a biotechnology company that reneged on a financing deal, claiming its position as the company's only secured creditor could cost it millions in losses.
-
March 11, 2021
Trading Firm Says 3rd Time's The Charm For $3.6M Award
A New York-based trading firm has urged a federal judge to confirm a revised $3.6 million international arbitration award against a biotechnology company that reneged on a financing deal, arguing the arbitrator's third calculation is right on the money.
-
April 24, 2020
Trading Firm's Arbitral Award Still Needs Some Clarity
A New York federal judge on Friday granted a trading firm's request to set aside and remand, again, part of an award that had been left ambiguous by an arbitrator in a dispute over an alleged breach of a financing agreement with Generex Biotechnology Corp.
-
July 31, 2019
Arbitrator Told To Clarify Trading Firm's $3.6M Award
A biotechnology company will not have to pay a $3.6 million arbitration award to a trading firm over an alleged breach of a financing agreement just yet after a New York federal judge sent it back to the arbitrator for clarification on whether the amount was properly calculated.
-
February 19, 2019
Biotech Co. Says $3.6M Award Wrongly Calculated
A biotechnology company urged a New York federal court not to enforce an arbitration award issued to a trading firm over an alleged breach of a financing agreement, arguing that the $3.6 million award was improperly calculated based on the value of stock warrants that are actually worthless.
-
February 05, 2019
Trading Firm Tries To Save $3.6M Int'l Arbitration Award
A New York-based trading firm has for a second time asked a federal court to enforce a more than $3.6 million international arbitration award against a biotechnology company, claiming it reneged on an exclusivity clause in an investor financing deal.
-
December 13, 2018
Biotech Co. On Hook For $3.6M Int'l Arb. Judgment, Court Told
A trading firm asked a New York federal court on Tuesday to enforce a $3.6 million international arbitration judgment against a biotechnology company that reneged on a financial arrangement.